APOLLO HOSPITALS ENTER. L vs FERMENTA BIOTECH LTD.

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and FERMENTA BIOTECH LTD. (FERMENTA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, FERMENTA BIOTECH LTD. leads APOLLOHOSP vs FERMENTA on 7 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability13
  • Growth10
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

FERMENTA takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
19.99
13.46
P/B ratio
2.55
0.22%
Dividend yield
0.78%
₹135.04
EPS
₹24.39

Profitability

FERMENTA takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
16.40%
17.31%
Return on capital
21.00%
14.94%
EBITDA margin
19.00%
7.94%
Net margin
13.38%

Growth

APOLLOHOSP takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
14.43%
33.35%
Profit CAGR (3Y) even
—

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.13L Cr
Market cap
₹1,430 Cr
₹25,229 Cr
Revenue
₹523 Cr
₹2,003 Cr
Net profit
₹70 Cr
0.90
Debt / equity
0.27
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 71.0% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.97 times its book value"]
FERMENTA BIOTECH LTD.
  • + []
  • − ["The company has delivered a poor sales growth of 6.8% over past five years."]
APOLLO HOSPITALS ENTER. L full analysis FERMENTA BIOTECH LTD. full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.